Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label Access to Dolutegravir for HIV-1 Infected Children and Adolescents Completing IMPAACT Studies P1093 and P2019

NCT03016533 is registered in ClinicalTrials.gov with ViiV Healthcare as lead sponsor.

NCT NCT03016533
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03016533 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label Access to Dolutegravir for HIV-1 Infected Children and Adolescents Completing IMPAACT Studies P1093 and P2019
Lead sponsor
ViiV Healthcare
Phase
Phase 3
Overall status
Completed
Start date
June 6, 2017
Completion date
December 24, 2024
Enrollment
100 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections